News
-
Decision 9C_169/2023 of 29 May 2024
-
Strengthening Measures Against Antibiotic Resistance
-
Go-live for the Swissdamed Actors Module
-
EU Actions to Address GLP-1 Receptor Agonist Shortages
-
Decision B-468/2022 of 11 June 2024
-
Decision 9C_115/2023 of 29 May 2024
-
Judgments of the Court of Justice in Cases C-144/19 P, C-151/19 P, C-164/19 P, C-166/19 P, C-176/19 P, C-197/19 P, C-198/19 P, C-201/19 P, C-207/19 P
-
Amendments to the Ordinance on Healthcare Benefits (Krankenpflege-Leistungsverordnung, KLV) Effective from 1 July 2024
-
Outpatient Tariffs: TARDOC and Flat Rates will replace TARMED in 2026
-
Changes to Declaration of Goods for the Export of Medicinal Products (including Clinical Trials) and Narcotics made to the Federal Office for Customs and Border Security (FOCBS)
-
Simplification of Requirements for Renewed Authorisation of Medicinal Products
-
Faster Access to Clinical Trial Information in Europe
-
Granting broader competences to Cantons in the approval of health insurance premiums
-
Human Research Act: Revision of Ordinances for enhanced protection of participants
-
Swissmedic publishes its Annual Report for 2023
-
Better representation of women in medical research
-
Fact sheet: Classification of essential oils – delimitation criteria
-
Two new advice pilots to improve clinical trials in Europe
-
Decision 9C_385/2023 of 8 May 2024
-
Interpretation in the context of tariff-compliant service invoicing according to TARMED
-
Changes to the Guidance document Time limits for authorisation applications